Clinical Trials Browser

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT06567782 2026-03-12

AZUR-4

Phase 2 Recruiting

120 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06830239 2026-02-12

Superhero

Phase 2 Recruiting

10 enrolled

Gastrointestinal

Colonic Neoplasms

NCT05700721 2026-02-05

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Phase 2 Recruiting

120 enrolled

CNS

Brain Neoplasms

NCT04774419 2026-02-03

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Phase 2 Recruiting

62 enrolled

Gynecologic

Endometrial Neoplasms

NCT07336147 2026-01-14

Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Phase 2 Recruiting

45 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07108270 2025-12-22

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

Phase 2 Recruiting

30 enrolled

Gynecologic

Endometrial Neoplasms

NCT05526989 2025-12-04

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Phase 2 Recruiting

25 enrolled

Genitourinary

Penile Neoplasms

NCT06333314 2025-12-02

Pan-MSI-ACSE

Phase 2 Recruiting

120 enrolled

EndocrineSarcoma

Neoplasm Metastasis, Neoplasms, Sarcoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine

NCT06023862 2025-06-15

DOVE

Phase 2 Recruiting

198 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT05239546 2025-05-25

NAIO

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06757244 2025-03-18

DOVIPA

Phase 2 Recruiting

35 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06278857 2024-12-03

SATELLITE

Phase 2 Recruiting

10 enrolled

Gynecologic

Turcot syndrome, Endometrial Neoplasms

NCT04817956 2024-02-29

IMPRESS-N

Phase 2 Recruiting

3,000 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06059495 2024-02-05

DEWI

Phase 2 Recruiting

59 enrolled

Gastrointestinal

Adenocarcinoma - GEJ

NCT04681469 2022-08-04

PRIME

Phase 2 Recruiting

49 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

I-SPY

AZUR-4

Superhero

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Pan-MSI-ACSE

DOVE

NAIO

DOVIPA

SATELLITE

IMPRESS-N

DEWI

PRIME